Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer.

Saved in:
Bibliographic Details
Title: Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer.
Authors: Otto-Dobos LD; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Grant CV; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Lahoud AA; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Wilcox OR; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Strehle LD; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Loman BR; Center for Microbial Pathogenesis and the Oral and Gastrointestinal Microbiology Research Affinity Group, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; Department of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana, IL, USA., Adarkwah Yiadom S; Division of Biostatistics, The Ohio State University, Columbus, OH, USA., Seng MM; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Halloy NR; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Russart KLG; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Carpenter KM; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Dawson E; Department of Neurology, The Ohio State University, Columbus, OH, USA., Sardesai SD; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Williams NO; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Gatti-Mays ME; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Stover DG; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sudheendra PK; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Wesolowski R; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Kiecolt-Glaser JK; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA., Bailey MT; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA; Center for Microbial Pathogenesis and the Oral and Gastrointestinal Microbiology Research Affinity Group, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Andridge RR; Division of Biostatistics, The Ohio State University, Columbus, OH, USA., Pyter LM; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA; Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH, USA. Electronic address: leah.pyter@osumc.com.
Source: Brain, behavior, and immunity [Brain Behav Immun] 2024 Aug; Vol. 120, pp. 208-220. Date of Electronic Publication: 2024 May 31.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8800478 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2139 (Electronic) Linking ISSN: 08891591 NLM ISO Abbreviation: Brain Behav Immun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2139
DOI:10.1016/j.bbi.2024.05.039